Navigation Links
Isis Reports Phase 2 Data on ISIS-APOCIII Rx Showing Significant Reductions of ApoC-III and Triglycerides in Patients With High Triglycerides Taking Fibrates
Date:7/22/2013

nd trends toward improvements in insulin sensitivity, suggest that ISIS-APOCIIIRx could have a broad therapeutic profile in addition to triglyceride lowering for patients with severely high triglycerides.  We are also pleased with the data reported today. They demonstrate that ISIS-APOCIIIRx is additive to fibrates with robust reductions of apoC-III and triglycerides," said Richard Geary, Ph.D., senior vice president of development at Isis.  "We look forward to sharing the results from our ongoing Phase 2 study evaluating ISIS-APOCIIIRx as a monotherapy in patients with severely high triglycerides.  In this study, we hope to show that treatment with ISIS-APOCIIIRx in patients with severely high triglycerides also produces significant effects on apoC-III, triglycerides and HDL-C.  Following completion of the Phase 2 program, we plan to discuss our Phase 3 plans with regulators and move rapidly into a Phase 3 program next year in patients with severely high triglycerides (greater than 880 mg/dL)." 

ISIS-APOCIIIRx is an antisense drug intended to treat patients with severely high triglycerides either as a single agent or in combination with other triglyceride-lowering agents.  ISIS-APOCIIIRx targets apoC-III, a gene produced in the liver that plays a central role in the regulation of serum triglycerides.  Humans who do not produce apoC-III have lower levels of triglycerides and lower instances of cardiovascular disease.  In clinical studies, patients with lower levels of apoC-III and triglycerides exhibit lower cardiovascular event rates.  Humans with elevated levels of apoC-III have increased dyslipidemia associated with multiple metabolic abnormalities, such as insulin resistance and/or metabolic syndrome.  In addition, the prevalence of type 2 diabetes is increased in patients with elevated triglycerides.Conference
'/>"/>

SOURCE Isis Pharmaceuticals, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6

Related medicine technology :

1. Qmed, the Leading Global MedTech Industry Resource, Partners with Clarimed, to Provide the Medical Manufacturing and Healthcare Industry with FDA Reports on Adverse Events
2. Sigma-Aldrich (NASDAQ: SIAL) Reports Q1 2012 Diluted EPS of $0.96, With Diluted Adjusted EPS of $0.99. Sales Increase 5% for Q1 2012. Full Year 2012 Diluted Adjusted EPS Outlook of $3.90 to $4.05 Reaffirmed.
3. Kelyniam Global Inc. Reports Record Cranial Implant Revenues in the 1st Quarter of 2012
4. Varian Medical Systems Reports Results for Second Quarter of Fiscal Year 2012
5. Mylan Reports Q1 2012 Adjusted Diluted EPS of $0.52, an 18% Increase Over Prior Year Quarter
6. CryoLife Reports Record Quarterly Revenues in First Quarter of 2012
7. PAREXEL Reports Third Quarter Fiscal Year 2012 Financial Results
8. Luminex Corporation Reports First Quarter 2012 Results
9. Hospira Reports First-Quarter 2012 Results
10. Endo Reports First Quarter Financial Results And Announces Return To Steady Supply Of OPANA® ER And Voltaren® Gel
11. The Female Health Company Reports Second Quarter Operating Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/25/2014)... SAN DIEGO , July 25, 2014  Arena ... it will provide a corporate update and report second ... Market opens on Friday, August 1, 2014. That same ... at 8:30 a.m. Eastern Time (5:30 a.m. Pacific Time). ... by dialing 877.643.7155 for domestic callers and 914.495.8552 for ...
(Date:7/24/2014)... PARK, Kan. , July 24, 2014 /PRNewswire/ ... of two compounds that will be added to ... with Australian-based CIMTECH Pty Ltd, a biotechnology company. ... PAR 122 have shown promise in bone regeneration ... license to develop the compounds for the veterinary ...
(Date:7/24/2014)... , Deutschland, und MARSEILLE ... , Weltweite Exklusivlizenz ... ermöglicht QIAGEN die Entwicklung von Tests auf ... Blutkrebs  Neuer Test weist Mutationen ... Knochenmarkserkrankungen (myelodysplastischen Syndromen) einen günstigen Krankheitsverlauf vermuten ...
Breaking Medicine Technology:Arena Pharmaceuticals to Host Corporate Update and Financial Results Conference Call and Webcast on Friday, August 1 2Arena Pharmaceuticals to Host Corporate Update and Financial Results Conference Call and Webcast on Friday, August 1 3Parnell Acquires License for Intellectual Property and Rights to Develop Compounds for Bone and Dermal Regeneration 2Parnell Acquires License for Intellectual Property and Rights to Develop Compounds for Bone and Dermal Regeneration 3Parnell Acquires License for Intellectual Property and Rights to Develop Compounds for Bone and Dermal Regeneration 4QIAGEN erweitert Pipeline für die personalisierte Medizin um vielversprechende genomische Biomarker zur Prognosebestimmung bei Blutkrebsbehandlungen 2QIAGEN erweitert Pipeline für die personalisierte Medizin um vielversprechende genomische Biomarker zur Prognosebestimmung bei Blutkrebsbehandlungen 3QIAGEN erweitert Pipeline für die personalisierte Medizin um vielversprechende genomische Biomarker zur Prognosebestimmung bei Blutkrebsbehandlungen 4QIAGEN erweitert Pipeline für die personalisierte Medizin um vielversprechende genomische Biomarker zur Prognosebestimmung bei Blutkrebsbehandlungen 5
... Corporation (NYSE: GPX ), a global ... technical training, e-Learning solutions, management consulting and engineering services, ... Esposito-Mayer will speak at the ROTH Capital Partners 24th ... PT. The conference will be held at The Ritz ...
... and NEW YORK, March 6, 2012   Access ... leveraging its proprietary drug-delivery platforms to develop treatments in ... lead product website, www.MuGard.com , with a new ... visit the Testimonials section of the MuGard site or ...
Cached Medicine Technology:Access Pharmaceuticals Updates MuGard.com With New Product Testimonial 2Access Pharmaceuticals Updates MuGard.com With New Product Testimonial 3
(Date:7/25/2014)... (PRWEB) July 25, 2014 Consuming too ... How to know? , Read the labels! , Learn ... determine how it relates to health during a "Healthy ... Aug. 1 at Humility House, 755 Ohltown Road, Austintown. ... lead an informational discussion and answer questions. , ...
(Date:7/25/2014)... City, UT (PRWEB) July 25, 2014 ... court surfaces for the recent Nike National Invitational ... the current United States Junior National Tournament (USJN) ... July 25. , The flooring for these prestigious national ... more than 300,000 square feet of playing surface at ...
(Date:7/25/2014)... 2014 As reported by People Magazine in ... Jersey Shore and Getting Sober (7/15), one of the ... has spoken out to the public about his personal transformation. ... The Situation admits that moving on with his life was ... and other drugs in 2012 and even spent some time ...
(Date:7/25/2014)... July 25, 2014 (HealthDay News) -- The human brain ... of dehydration, a new study finds. Although ... in England have found that the brain compensates by ... blood. "This research has helped us understand a ... extreme exercise in extreme conditions," study first author Steven ...
(Date:7/25/2014)... Art of Facial Surgery has recently stepped up ... who are looking for minor touch-ups to make them more ... American Academy of Facial Plastic and Reconstructive Surgery (AAFPRS) ... surgery showed a surprising increase between 2012 and 2013. ... transplants increased by 7 percent and eyelid surgery increased by ...
Breaking Medicine News(10 mins):Health News:Learn to Decipher Food Labels at Humility House 2Health News:Sport Court Provides All Sports Flooring for Basketball Events in Chicago and Washington D.C. 2Health News:'The Situation' Celebrates 8 Months of Sobriety 2Health News:'The Situation' Celebrates 8 Months of Sobriety 3Health News:Human Brain Has Coping Mechanism for Dehydration 2Health News:Art of Facial Surgery Responds to Demand for Facial Plastic Surgery Increase Due to the Popularity of Selfies 2Health News:Art of Facial Surgery Responds to Demand for Facial Plastic Surgery Increase Due to the Popularity of Selfies 3
... , , , ... Dr. Raymond Boyle, Ph.D., M.P.H., will be the new Director of ... and Epidemiology from the University of Oregon and the University of ... this new addition to ClearWay Minnesota and our research department," said ...
... explain why some function fine on six hours a night , ... by just fine on six hours of sleep, and a new ... finding doesn,t appear likely to help people with insomnia. Still, it ... long as they do, said study co-author Ying-Hui Fu, a professor ...
... Aug. 13 The following statement was released today by United ... comprehensive health care has been a high priority for the disability ... Act (H.R. 3200) will make significant strides toward meeting that goal. ... , Major insurance market reforms such as ...
... , BASKING RIDGE, N.J., Aug. 13 ... record-keeping, protecting confidential patient information becomes vastly more complex. ... designed to help safeguard the growing exchange of electronic patient ... , The first offering, Verizon Security Management ...
... , , , , ... busy preparing their children for departure for school, it is just ... from bringing bed bugs home from college and their travels. ... in the New York Metropolitan area, has seen a significant increase ...
... , MIAMI BEACH, Fla., Aug. 13 Centers ... facilities in Florida at the Florida Health Care Conference in Hollywood, ... for pressure ulcer management from the Florida Agency for Health Care ... Weaver, Chief of Field Operations, Division of Managed Care and Health ...
Cached Medicine News:Health News:They Snooze Less, But They Don't Lose 2Health News:Verizon Introduces New IT Security Capabilities for Health Care Industry 2Health News:Verizon Introduces New IT Security Capabilities for Health Care Industry 3Health News:Verizon Introduces New IT Security Capabilities for Health Care Industry 4Health News:Bed Bug Epidemic and Upcoming School Breaks Could Wreak Havoc on Homeowners 2Health News:Bed Bug Epidemic and Upcoming School Breaks Could Wreak Havoc on Homeowners 3Health News:Centers of Excellence Awards Presented to Over 100 Nursing Facilities as Nursing Facilities Reach the 'Tipping Point' in Treating Pressure Ulcers 2
... knee manufacturers focus attention on implant design, ... The Profix Total Knee System seeks to ... implant system and the tools to implant ... widely recognized for innovation in total knee ...
Cruciate retaining, posterior stabilized and constrained components....
Cruciate retaining, posterior stabilized and constrained components....
Maximum contact. Minimum wear. Outstanding results....
Medicine Products: